As per the latest report by Renub Research titled “Pediatric Vaccines Market, Size, Forecast 2022-2027, Share, Growth, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” Pediatric Vaccines Market Size was US$ 47.8 Billion by 2021. The vaccines administered to stop children from contracting several infectious diseases and non-infectious are pediatric vaccines. These vaccines are heat-killed or inactivated viruses that lose their pathogenicity, i.e., the ability to cause disease. Additionally, these inactivated antigens can stimulate the immune system to produce antibodies against the infected virus.
Besides, pediatric vaccines are distributed to a child in its pediatric age, from 0 –18 years. Vaccines are commonly given to prevent children from diseases transferred through seasonal variations, infections, and even though unhygienic areas. Depending upon the disorder, the vaccines are administered at regular intervals. World Health Organization (WHO) has designed a standard immunization program to have desired time interval between vaccines doses.
Pediatric Vaccine Growth Factors
Globally, the growing prevalence of chronic disorders such as diphtheria, tuberculosis, and pneumonia in the age of 15 years and downward will contribute to the development of the pediatric vaccines industry. According to WHO, globally around 5 billion severe illnesses and 0.5 billion deaths yearly. As immunization plays a vital role in modern medicine, several international programs for children may vary based on the disease. Nevertheless, these programs are primarily driving the demand in the pediatric vaccines market. Further, the global pediatric vaccines market is driven by factors such as the global initiative undertaken by key players to develop innovative vaccines and increase government support.
Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=pediatric-vaccines-market-p.php
The Combos Vaccine Segment is to Grow at a Significant Rate:
Based on Vaccine Types, the Pediatric Vaccine industry includes Influenza, MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, DTaP, mophilus Influenzae Type B (HIB), Combos (Combination), Polio, Rotavirus, Varicella and Coronavirus (COVID-19). Infections are always a leading cause of mortality and morbidity in children under 5 years of age, most of which can be stopped by vaccination. However, too many vaccines are to be administered, increasing the cost of immunization and visits to the pediatrician. Combination vaccines can answer these problems until developing a single vaccine containing all the possible antigens.
Additionally, combination vaccines such as the 5-in-1 and the MMR have been developed to help reduce the number of injections needed. Even so, children and babies often receive several vaccines at once. For example, a 2-month-old baby will simultaneously obtain the 5-in-1, PCV, Rotavirus, and MenB vaccines. Moreover, as per our Report statistics, the number of infants vaccinated from Combination Vaccines across the world was 163.52 Million in 2021, and it increased appreciably to 339.04 Million by 2027.
COVID-19 Impact on Global Pediatric Vaccines Market:
The COVID-19 has upended the lives of children and their families. Therefore, amidst the pandemic, the global market for Pediatric vaccines dropped in 2020 as most healthcare personnel were busy in COVID-19 management. The pandemic naturally affected the routine immunization programs and campaigns conducted globally in developing and developed countries. The UNICEF and World Health Organization (WHO) warned of an alarming drop in the number of children receiving life-saving vaccines worldwide. This is due to troubles in the delivery and uptake of immunization services caused by the COVID-19 pandemic.
Regardless, Influenza vaccination rates have gone up considerably during the pandemic due to push from health experts/health departments and the extension of different government programs that provide free vaccination against the flu. Also, growing awareness among the public about the higher risk of getting infected with COVID-19 if the flu weakens the immune system is another factor contributing to the uptake of flu vaccines.
The pediatric vaccines industry consists of several major players, including GlaxoSmithKline, Plc, Merck & Co., Sanofi Pasteur’s, Pfizer, Inc.’s, CSL Limited. The companies enforce specific strategic initiatives like new product launches, mergers, acquisitions, and partnerships, which help them strengthen their market position.
Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/pediatric-vaccines-market-p.php
- Vaccine Types – We have covered Global Pediatric Vaccines Market & Numbers of Population breakup by 2 viewpoints by Vaccine Type (Influenza, MMR (Measles, Mumps, and Rubella Vaccine), Pneumococcal, Meningococcal, Hepatitis, DTaP, mophilus Influenzae Type B (HIB), Combos (Combination), Polio, Rotavirus, Varicella and Coronavirus (COVID-19))
- Regions – We have covered all the 5 Regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa in this report
- All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) GlaxoSmithKline, Plc, Merck & Co., Sanofi Pasteur’s, Pfizer, Inc.’s, CSL Limited.
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more. Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today’s ultra-competitive markets.
Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)
Follow on Linkedin: https://www.linkedin.com/company/renub-research
Follow on Twitter: @renubresearch